Online edition zviazda.by

The Emirates Drug Establishment (EDE) has approved a new therapeutic indication for RINVOQ (upadacitinib) to treat non-segmental vitiligo in adults and adolescents aged 12 years and older whose condition requires systemic therapy through medicines that circulate in the bloodstream, making it the first licensed oral treatment for this group of patients.

Belarusian Healthcare Minister Aleksandr Khodzhayev discussed the development of the country’s cooperation with other states in the healthcare sector in an interview with STV TV channel, BelTA has learned.

Tanzania’s Prime Minister Kassim Majaliwa expressed interest in Belarus’ pharmaceutical industry and offered support for investment to enhance Tanzania’s pharmaceutical production.